Fleur A. de Groot

机构：Leiden University Medical Center · ORCID：0000-0001-9940-2891

发表论文 23 篇 · 总被引 126 次 · h-index 8

代表论文

• Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype (2021 · Blood Advances · 被引 19)
• Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas (2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 15)
• Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies (2024 · European Journal of Cancer · 被引 13)
• Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach (2022 · Cancers · 被引 12)
• Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features (2024 · Blood Advances · 被引 10)
• Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma (2024 · Clinical Pharmacokinetics · 被引 9)